SensoDetect Investor Relations Material
Latest events
Q1 2025
30 Apr, 2025
Q4 2024
21 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SensoDetect
Access all reports
SensoDetect AB is a Sweden-based medical technology company specializing in objective diagnostic tools for mental health. The company develops and markets the SensoDetect BERA system, which uses auditory brainstem response analysis to support the diagnosis of neuropsychiatric disorders such as ADHD, autism, and schizophrenia. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
SDET
Country
🇸🇪 Sweden